Moneycontrol PRO
HomeNewsBusinessEarningsTorrent Pharma posts Rs 118 crore Q4 loss on impairment provision

Torrent Pharma posts Rs 118 crore Q4 loss on impairment provision

Torrent Pharma announced on Wednesday that its consolidated loss for the fourth quarter ended March 2022 was Rs 118 crore, owing to an impairment charge of Rs 425 crore relating to the cessation of its liquids business in the United States.

May 25, 2022 / 20:13 IST
Representative image

Representative image

Torrent Pharma on Wednesday said its consolidated loss stood at Rs 118 crore for the fourth quarter ended March 2022 on account of impairment provision of Rs 425 crore related to discontinuation of liquids business in the US. The company had reported a net profit of Rs 324 crore in the January-March period of 2020-21 fiscal. Revenue rose to Rs 2,131 crore during the period under review as against Rs 1,937 crore in the same period of FY21.

For the entire 2020-21 fiscal, the drug major posted a consolidated net profit of Rs 777 crore as compared with Rs 1,252 crore in the preceding fiscal. Revenues rose to Rs 8,508 crore last fiscal. The same stood at Rs 8,005 crore in FY21. ”The branded businesses contributed to 70 per cent of total revenues in Q4 and grew by 15 per cent with India and Brazil continuing on a strong footing. The US business registered sequential growth aided mainly by launch of a new product,” Torrent Pharma Chairman Samir Mehta said in a statement. ”

While the EU business faced some headwinds, the drug maker remains optimistic that the cost efficiency measures being taken will bring it back to growth in this market in the coming quarters, he added. ”We have taken a difficult decision of discontinuing our liquids business in the US. We believe the incremental investments required will exceed the potential economic benefits in this segment due to changing market conditions, as economics and competitive intensity have turned unfavourable compared to the time of conceptualisation,” Mehta noted. ”

The company said its board has approved to seek shareholder nod to raise up to Rs 5,000 core through various means including Qualified Institutional Placement (QIP). The company’s board has also approved a final dividend of Rs 23 per equity share of Rs 5 each, including the special dividend of Rs 15 per share.

The final dividend amount, if declared by the shareholders, is proposed to be paid/dispatched on or around August 4, 2022, it added.

PTI
first published: May 25, 2022 08:13 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347